Biondini Davide, Damin Marco, Bonifazi Martina, Cocconcelli Elisabetta, Semenzato Umberto, Spagnolo Paolo, Gasparini Stefano, Saetta Marina, Balestro Elisabetta
Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35128 Padova, Italy.
Pulmonary Disease Unit, Department of Internal Medicine, Azienda Ospedali Riuniti, 60126 Ancona, Italy.
Diagnostics (Basel). 2021 Oct 19;11(10):1938. doi: 10.3390/diagnostics11101938.
Bronchoscopy has several major diagnostic and therapeutic indications in pulmonology. However, it is an aerosol-generating procedure that places healthcare providers at an increased risk of infection. Now more than ever, during the spread of the coronavirus disease 2019 (COVID-19) pandemic, the infectious risk during bronchoscopy is significantly raised, and for this reason its role in diagnostic management is debated. In this review, we summarized current evidence regarding the indications for bronchoscopy and the measures that should be applied to decrease risk exposure. Indeed, seeing the long-lasting period of the pandemic, resuming standard of care for all patients is required.
支气管镜检查在肺病学中有几个主要的诊断和治疗适应症。然而,它是一种会产生气溶胶的操作,会增加医护人员的感染风险。在2019冠状病毒病(COVID-19)大流行期间,支气管镜检查期间的感染风险比以往任何时候都显著提高,因此其在诊断管理中的作用存在争议。在本综述中,我们总结了关于支气管镜检查适应症以及应采取哪些措施降低风险暴露的现有证据。事实上,鉴于大流行的持续时间很长,需要恢复对所有患者的标准治疗。